Tuesday, May 5, 2026
Today's Print

Tag: InterVenn Biosciences

InterVenn launching

Officials of InterVenn Biosciences including (L-R) Randy Barr, chief information and security officer; Axel Kornerup, general manager; Dan Serie, chief data officer; Erwin Estigarribia,...

Filipino-led Biotech raises P10 billion to advance revolutionary cancer research

InterVenn Biosciences recently announced the completion of a P10 Billion Series C financing from SoftBank Group, Heritage Provider Network, Irving Investors, and Highside Capital...

InterVenn raises P10 billion

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 11.0px; font: 9.0px 'Myriad Pro'} span.s1 {font: 11.0px 'Myriad Pro'} InterVenn Biosciences announces the completion of a P10-billion Series...

Filipino-led Intervenn Biosciences raises more than P2 billion to aid in ovarian cancer research and immuno-oncology

InterVenn Biosciences announced it has raised US$34 million in Series B fundraising -- translating to more than P2 billion -- for the biotech company...

Filipinos in Silicon Valley disrupt cancer research

The 2015 Philippine Cancer Facts and Estimates published by the Philippine Cancer Society identified the ovary as among the top ten leading new cancer...
- Advertisement -spot_img
- Advertisement -spot_img